Equities

Gyre Therapeutics Inc

Gyre Therapeutics Inc

Actions
  • Price (EUR)14.70
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, Gyre Therapeutics Inc increased its cash reserves by 33.10%, or 8.33m. The company earned 25.89m from its operations for a Cash Flow Margin of 22.82%. In addition the company generated 2.50m cash from financing while 19.76m was spent on investing.
Cash flow per share-0.5759
Price/Cash flow per share--
Book value per share0.7056
Tangible book value per share0.7034
More ▼

Balance sheet in USDView more

Gyre Therapeutics Inc uses little or no debt in its capital structure.
Current ratio3.44
Quick ratio3.07
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.